Obesity Complications Beyond the Scale

ABCD is defined by the severity of complications. We move beyond BMI to understand how adiposity affects four critical health domains and their interconnected pathophysiology.

Adiposopathy - or "sick fat" - is the pathological state of adipose tissue characterized by inflammation, ectopic lipid accumulation, impaired metabolic function, and dysregulated cytokine production. This dysfunctional tissue is the root cause of complications across all domains.

Metabolic

Functional and structural complications of adipose tissue dysfunction and lipotoxicity.

Type 2 Diabetes

Insulin resistance and β-cell dysfunction leading to hyperglycemia

Dyslipidemia

Abnormal lipid profiles with elevated triglycerides and reduced HDL

NAFLD/NASH

Non-alcoholic fatty liver disease progressing to inflammation and fibrosis

Insulin Resistance

Reduced cellular response to insulin signaling and GLUT4 dysfunction

Diagnostic Criteria

  • Fasting glucose > 100 mg/dL
  • HbA1c ≥ 5.7%
  • HOMA-IR > 2.5
  • Triglycerides > 150 mg/dL
  • AST/ALT elevation

Clinical Management

  • Metformin
  • GLP-1 agonists
  • SGLT2 inhibitors
  • Thiazolidinediones
  • Dietary modification
  • Weight loss programs

Biomechanical

Complications from mechanical burden and pressure effects of excess adiposity.

Obstructive Sleep Apnea

Airway collapse during sleep due to soft tissue obstruction

Osteoarthritis

Joint cartilage degradation from chronic mechanical stress

Gastroesophageal Reflux

Increased intra-abdominal pressure affecting lower esophageal sphincter

Hypoventilation

Reduced lung capacity from diaphragmatic compression

Diagnostic Criteria

  • Apnea-Hypopnea Index (AHI)
  • Oxygen desaturation index
  • Functional capacity testing
  • Joint imaging findings

Clinical Management

  • CPAP/BiPAP therapy
  • Physical therapy
  • Weight loss
  • Anti-inflammatory medications
  • Surgical interventions if severe

Cardiovascular

Cardiac and vascular complications from systemic inflammation and metabolic dysfunction.

Hypertension

Elevated blood pressure from insulin resistance and sodium retention

Heart Failure

Impaired cardiac function with reduced ejection fraction (HFrEF) or diastolic dysfunction (HFpEF)

Coronary Artery Disease

Atherosclerotic plaque formation and arterial narrowing

Atrial Fibrillation

Arrhythmia from atrial remodeling and inflammatory state

Diagnostic Criteria

  • Blood pressure ≥ 130/80 mmHg
  • BNP > 100 pg/mL
  • LDL cholesterol
  • Coronary calcium score
  • Troponin elevation

Clinical Management

  • ACE inhibitors/ARBs
  • Beta-blockers
  • Statins
  • GLP-1 agonists
  • SGLT2 inhibitors
  • Aspirin therapy
  • Revascularization if needed

Psychological

Mental health and psychosocial complications of adiposity-related disease.

Clinical Depression

Major depressive disorder linked to inflammatory cytokines and metabolic dysfunction

Anxiety Disorders

Generalized anxiety, panic disorder, and social anxiety related to weight concerns

Body Image Disorders

Negative self-perception and dissatisfaction with physical appearance

Eating Disorders

Disordered eating patterns and maladaptive food relationships

Diagnostic Criteria

  • PHQ-9 score > 10
  • GAD-7 score > 10
  • Quality of life assessments
  • Psychological screening tools

Clinical Management

  • Cognitive behavioral therapy (CBT)
  • Antidepressants (SSRIs/SNRIs)
  • Counseling services
  • Support groups
  • Integrated mental health care

Systemic Impact Explorer

Section 02 — Systemic Impact

Complications Beyond the Scale.

ABCD is defined by the severity of complications. We move beyond BMI to look at how adiposopathy affects four critical health domains.

Metabolic

  • Type 2 Diabetes
  • Dyslipidemia
  • NAFLD / NASH
  • Insulin Resistance
Diagnostic MarkerHOMA-IR / Lipid Profile

Biomechanical

  • Sleep Apnea
  • Osteoarthritis
  • GERD
  • Urinary Incontinence
Diagnostic MarkerAHI / Physical Function

Cardiovascular

  • Hypertension
  • Heart Failure
  • Coronary Artery Disease
  • Atrial Fibrillation
Diagnostic MarkerBlood Pressure / BNP

Psychological

  • Clinical Depression
  • Body Image Disorders
  • Anxiety
  • Stigmatization
Diagnostic MarkerPHQ-9 / QoL Score

Explore the Pathophysiology

Understand the molecular mechanisms of Lipotoxicity and multi-organ dysfunction driving ABCD complications.

Molecular Mechanism Illustration

Obesity Related Diseases and Comorbidity Interactions

Complications often interact and compound each other. For example, metabolic dysfunction increases cardiovascular risk, which may limit physical capability, worsening both metabolic and psychological outcomes.

Common Comorbidity Patterns

Metabolic-Cardiovascular Axis

Type 2 Diabetes → Hypertension → CAD → Heart Failure

Biomechanical-Metabolic Loop

Sleep Apnea → Hypoxia → Insulin Resistance → OSA progression

Psychological-Metabolic Interaction

Depression → Poor adherence → Metabolic decompensation → Worsening depression

Systemic Inflammation Loop

Adiposopathy → Elevated TNF-α, IL-6 → Multi-organ dysfunction across all domains

Related Health Information

What is ABCD?

Overview of the ABCD framework and core principles.

ABCD Stages

Four stages of ABCD with clinical characteristics and interventions.

Clinical Resources

Guidelines and tools for managing ABCD complications.

Complication Questions

What are common obesity complications?

Common obesity complications include insulin resistance, type 2 diabetes, dyslipidemia, sleep apnea, hypertension, cardiovascular disease, and psychosocial complications across multiple domains.

How does visceral fat increase health risk?

Visceral fat contributes to adipose tissue dysfunction, chronic inflammation, and cardiometabolic risk, increasing the likelihood of metabolic syndrome and obesity-related disease progression.